136 related articles for article (PubMed ID: 22172144)
1. Guillain-Barre syndrome: first description of a snake envenomation aetiology.
Neil J; Choumet V; Le Coupanec A; d'Alayer J; Demeret S; Musset L
J Neuroimmunol; 2012 Jan; 242(1-2):72-7. PubMed ID: 22172144
[TBL] [Abstract][Full Text] [Related]
2. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
[TBL] [Abstract][Full Text] [Related]
3. [Guillain-Barré syndrome with high titers of anti-GM2 and anti-GalNAc-GD1a antibody following cytomegalovirus hepatitis].
Shimoya K; Ohnishi A; Hashimoto T; Yuki N
Rinsho Shinkeigaku; 1997 Feb; 37(2):106-10. PubMed ID: 9164140
[TBL] [Abstract][Full Text] [Related]
4. Are anaphylactic reactions to snake bites immunoglobulin E-mediated?
Reimers AR; Weber M; Müller UR
Clin Exp Allergy; 2000 Feb; 30(2):276-82. PubMed ID: 10651780
[TBL] [Abstract][Full Text] [Related]
5. Lipopolysaccharides in the development of the Guillain-Barré syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral neuropathies.
Prendergast MM; Moran AP
J Endotoxin Res; 2000; 6(5):341-59. PubMed ID: 11521055
[TBL] [Abstract][Full Text] [Related]
6. Cross-reactive antibodies against GM2 and CMV-infected fibroblasts in Guillain-Barré syndrome.
Ang CW; Jacobs BC; Brandenburg AH; Laman JD; van der Meché FG; Osterhaus AD; van Doorn PA
Neurology; 2000 Apr; 54(7):1453-8. PubMed ID: 10751257
[TBL] [Abstract][Full Text] [Related]
7. [A case of Guillain-Barré syndrome associated with anti-GM2 antibody due to cytomegalovirus infection--special reference to the effect of ganciclovir].
Niwa K; Kitagawa Y; Ohta T; Shinohara Y; Saito T
Rinsho Shinkeigaku; 1995 Jun; 35(6):652-6. PubMed ID: 8521643
[TBL] [Abstract][Full Text] [Related]
8. Anti-ganglioside complex IgM antibodies in multifocal motor neuropathy and chronic immune-mediated neuropathies.
Nobile-Orazio E; Giannotta C; Briani C
J Neuroimmunol; 2010 Feb; 219(1-2):119-22. PubMed ID: 20006388
[TBL] [Abstract][Full Text] [Related]
9. Acute axonal Guillain-Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides.
Illa I; Ortiz N; Gallard E; Juarez C; Grau JM; Dalakas MC
Ann Neurol; 1995 Aug; 38(2):218-24. PubMed ID: 7654069
[TBL] [Abstract][Full Text] [Related]
10. Campylobacter coli enteritis and Guillain-Barré syndrome: no evidence of molecular mimicry and serological relationship.
Funakoshi K; Koga M; Takahashi M; Hirata K; Yuki N
J Neurol Sci; 2006 Jul; 246(1-2):163-8. PubMed ID: 16600306
[TBL] [Abstract][Full Text] [Related]
11. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a.
Tatsumoto M; Koga M; Gilbert M; Odaka M; Hirata K; Kuwabara S; Yuki N
J Neuroimmunol; 2006 Aug; 177(1-2):201-8. PubMed ID: 16844234
[TBL] [Abstract][Full Text] [Related]
12. Complete recovery of an aged patient with Guillain-Barré syndrome associated with multiple IgM anti-ganglioside antibodies.
Furiya Y; Hirano M; Kusunoki S; Ueda M; Sugie K; Nishiwaki T; Ueno S
Muscle Nerve; 2008 Dec; 38(6):1630-3. PubMed ID: 19016534
[TBL] [Abstract][Full Text] [Related]
13. Prospective study on anti-ganglioside antibodies in childhood Guillain-Barré syndrome.
Schessl J; Koga M; Funakoshi K; Kirschner J; Muellges W; Weishaupt A; Gold R; Korinthenberg R
Arch Dis Child; 2007 Jan; 92(1):48-52. PubMed ID: 16920757
[TBL] [Abstract][Full Text] [Related]
14. Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome.
Koga M; Takahashi M; Masuda M; Hirata K; Yuki N
Neurology; 2005 Nov; 65(9):1376-81. PubMed ID: 16162859
[TBL] [Abstract][Full Text] [Related]
15. The Guillain-Barré syndrome: a true case of molecular mimicry.
Ang CW; Jacobs BC; Laman JD
Trends Immunol; 2004 Feb; 25(2):61-6. PubMed ID: 15102364
[TBL] [Abstract][Full Text] [Related]
16. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].
Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM
Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060
[TBL] [Abstract][Full Text] [Related]
17. Serum antibodies to gangliosides in Guillain-Barré syndrome.
Ilyas AA; Willison HJ; Quarles RH; Jungalwala FB; Cornblath DR; Trapp BD; Griffin DE; Griffin JW; McKhann GM
Ann Neurol; 1988 May; 23(5):440-7. PubMed ID: 3133978
[TBL] [Abstract][Full Text] [Related]
18. Hypersensitivity to airborne spitting cobra snake venom.
Prescott RA; Potter PC
Ann Allergy Asthma Immunol; 2005 May; 94(5):600-3. PubMed ID: 15945564
[TBL] [Abstract][Full Text] [Related]
19. Association of anti-GM2 antibodies in Guillain-Barré syndrome with acute cytomegalovirus infection.
Irie S; Saito T; Nakamura K; Kanazawa N; Ogino M; Nukazawa T; Ito H; Tamai Y; Kowa H
J Neuroimmunol; 1996 Aug; 68(1-2):19-26. PubMed ID: 8784256
[TBL] [Abstract][Full Text] [Related]
20. Antigenic cross-reactivity and species-specific identification of Pseudocerastes persicus fieldi snake venom.
Ibrahim NM; El-Kady EM
Toxicon; 2016 Sep; 119():194-202. PubMed ID: 27319296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
